Insider Trading

YMAB Stock  USD 5.00  0.08  1.63%   
About 59% of Y MAbs' investor base is looking to short. The analysis of the overall investor sentiment regarding Y mAbs Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Y MAbs' historical and current headlines, can help investors time the market. In addition, many technical investors use Y mAbs Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Y mAbs Therapeutics Executive. Insider Public Trading

Read at news.google.com
Google News at Macroaxis
  

Y mAbs Therapeutics Current Investor Sentiment

Comfort Level 41

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Y MAbs' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Y mAbs Therapeutics.

Y MAbs Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Y MAbs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Y MAbs Fundamental Analysis

We analyze Y MAbs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Y MAbs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Y MAbs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Y MAbs is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Y mAbs Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Y MAbs stock to make a market-neutral strategy. Peer analysis of Y MAbs could also be used in its relative valuation, which is a method of valuing Y MAbs by comparing valuation metrics with similar companies.

Peers

Y MAbs Related Equities

ZNTLZentalis Pharmaceuticals   4.95   
0%
93.0%
PASGPassage Bio   4.17   
0%
78.0%
ERASErasca   3.38   
0%
63.0%
ARQTArcutis Biotherapeutics   1.43   
0%
26.0%
LRMRLarimar Therapeutics   1.20   
0%
22.0%
PCVXVaxcyte   0.27   
0%
5.0%
EWTXEdgewise Therapeutics   0.88   
16.0%
0%
RVMDRevolution Medicines   0.99   
18.0%
0%
KRONKronos Bio   1.14   
21.0%
0%
MRSNMersana Therapeutics   1.16   
21.0%
0%
DAWNDay One   1.20   
22.0%
0%
TVTXTravere Therapeutics   1.44   
27.0%
0%
BLUEBluebird Bio   1.52   
28.0%
0%
MIRMMirum Pharmaceuticals   1.78   
33.0%
0%
MRUSMerus BV   2.21   
41.0%
0%
SNDXSyndax Pharmaceuticals   2.77   
52.0%
0%
CCCCC4 Therapeutics   3.20   
60.0%
0%
STROSutro Biopharma   3.75   
70.0%
0%
GBIOGeneration Bio   3.85   
72.0%
0%
BDTXBlack Diamond   5.32   
100.0%
0%

Complementary Tools for YMAB Stock analysis

When running Y MAbs' price analysis, check to measure Y MAbs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Y MAbs is operating at the current time. Most of Y MAbs' value examination focuses on studying past and present price action to predict the probability of Y MAbs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Y MAbs' price. Additionally, you may evaluate how the addition of Y MAbs to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance